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Tumors evade adaptive and/or innate immune response
multiple mechanisms including loss and/or down-regu-
lation of HLA class I antigens due to reduced or
impaired expression of single or multiple components of
the antigen processing machinery (APM), loss of co-
stimulatory molecules, expression of co-inhibitory
molecules including B7-H family members as well as of the
non-classical HLA-G antigen. This could lead to a reduced
immune response mediated by various immune cell subpo-
pulations. Due to the identification of microRNAs (miRs)
that play a key role in tumor formation and/or suppression
and in modulating immune cell differentiation as well as
adaptive and innate immune responses the complexity of
the molecular mechanisms of immune escape of tumors
has increased. Therefore, the aim of the study is to deter-
mine the impact of miRs on tumor immune surveillance by
identification of miRs modulating the expression of single
or multiple APM components, B7-H1 molecules and/or
HLA-G using different experimental approaches. In silico
analysis, miR arrays, deep sequencing, luciferase reporter
assays as well as enrichment of miRs by miTRAP led to the
identification of a number of miRs involved in the different
immune escape mechanisms. These distinct miRs identified
functionally regulate the expression of the respective
immune modulatory molecules, which directly affect the
immune recognition of tumor cells. Furthermore, combin-
ing immunohistochemistry with miR expression using a tis-
sue microarray revealed an inverse relationship of miR and
HLA-G expression, which was associated with an increased
tumor grading, but not with an enhanced tumor patients’
survival. Furthermore, overexpression of these immune
modulatory miRs results in altered protein expression pat-
tern. In particular a high frequency of differentially
expressed proteins involved in the cellular metabolism, cell
proliferation, apoptosis and gene transcription could be
identified suggesting that miRs exert a dual role by
modulating both the tumorigenicity as well as the immu-
nogenicity of tumor cells. Thus, these miRs might provide
novel therapeutic targets and/or might be used as diagnos-
tic or prognostic tools in cancers.
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